Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Navidea Biopharmaceuticals Inc (NYSE American:NAVB)

0.4161
Delayed Data
As of Oct 20
 -0.0004 / -0.10%
Today’s Change
0.29
Today|||52-Week Range
1.16
-34.73%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close0.42
Today’s open0.42
Day’s range0.41 - 0.42
Volume196,932
Average volume (3 months)262,383
Market cap$67.5M
Dividend yield--
Data as of 7:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)+50.00%
Earnings growth (this year)+111.11%
Earnings growth (next 5 years)--
Revenue growth (last year)+65.82%
P/E ratioNM
Price/Sales4.51
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CXRXConcordia Internatio...-0.36-38.71%
SPHSSophiris Bio Inc+0.09+4.02%
PTNPalatin Technologies...+0.00+0.27%
NBYNovaBay Pharmaceutic...-0.15-3.37%
Data as of 7:59pm ET, 10/20/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$22.0M
Annual profit (last year)-$14.3M
Net profit margin-65.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mike M. Goldberg
CFO, COO, Secretary &
Treasurer
Jed Andrew Latkin
Corporate headquarters
Dublin, Ohio

Forecasts